Aphea.Bio offers research and development in the areas of bioinsecticides and bioherbicides.
Aphea.Bio has raised $77.1M in total funding. The most recent round was Series C. The last funding was announced in July 2023.
Aphea.Bio's investors include Bill & Melinda Gates Foundation, Innovation Industries, European Circular Bioeconomy Fund, V-Bio Ventures, Qbic Fund.
Aphea.Bio is headquartered in Zwijnaarde, Belgium.
Aphea.Bio offers research and development in the areas of bioinsecticides and bioherbicides.
Aphea.Bio is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Aphea.Bio — Funding & Investors." VCBacked, July 11, 2023, https://www.vcbacked.co/company/apheabio. Accessed July 31, 2026.
VCBacked. (2023). Aphea.Bio — Funding & Investors. Retrieved July 31, 2026, from https://www.vcbacked.co/company/apheabio
{{cite web |title=Aphea.Bio — Funding & Investors |url=https://www.vcbacked.co/company/apheabio |website=VCBacked |access-date=July 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated